Wolf‐Dieter Fessner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wolf‐Dieter Fessner has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
Laurence Hecquet
Institut de Chimie de Clermont-Ferrand CNRS Auvergne Clermont INP Université Clermont Auverne 63000 Clermont-Ferrand France
5 shared publicationsDirk Heyl
Institut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Alarich-Weiss-Straße 4, 64287 Darmstadt, Germany Fax: +49(6151)166636
4 shared publications- Dong Yi
School of Life Science and Technology National College of Elite Engineers Tongji University Shanghai China
4 shared publications Michael Kickstein
Institut für Organische Chemie und Biochemie Technische Universität Darmstadt Peter-Grünberg-Str. 4 64287 Darmstadt Germany
4 shared publications- Pere Clapés
Department of Biological Chemistry Institute for Advanced Chemistry of Catalonia (IQAC‐CSIC) Jordi Girona 18–26 Barcelona 08034 Spain
4 shared publications Anna Szekrenyi
Technische Universität Darmstadt, Peter-Grünberg-Straße 4, 64287 Darmstadt, Germany
3 shared publications
Latest Publications
- Open Access
Ultrahigh-throughput screening for sialic acid-active enzymes in the microbial genetic diversity
Sialic acids (Sias) and related nonulosonic acids are critical components of glycoconjugates involved in host-pathogen interactions, immune regulation, and cell signalling. Despite their biotechnological relevance, the diversity of enzymes involved in Sia biosynthesis remains largely underexplored due to limitations in culture-dependent methods and the lack of (ultra)high-throughput screening strategies. Here, we report the development of a highly sensitive droplet-based microfluidic screening platform enabling the functional discovery of sialic acid aldolases in environmental metagenomes. The method integrates a fluorescence-coupled enzymatic cascade compatible with fluorescence-activated droplet sorting (FADS), allowing the screening of >10⁶ droplets per experiment, as well as a downstream validation strategy for the selected hits. Although some limitations were identified, the system demonstrated high sensitivity and was utilised for the screening of a metagenomic library from garden soil. During this campaign, a potential new sialic acid aldolase enzyme was identified. This work establishes a generalizable framework for measuring complex, multi-step enzymatic functions at ultrahigh throughput using coupled cascades in droplets, with direct applicability to directed evolution and activity-guided functional metagenomics. Highlights: Enzymatic cascade assay reports sialic acid aldolase activity in droplets. Dual fluorescence signal enables droplet quality control and barcoding. Optimized lysis and FADS enable plasmid recovery after droplet sorting. Droplet assay enriches NanA-positive clones by over 700-fold. Soil metagenome screening retrieves aldolase-related candidates Graphical Fig. 1. Optimization of a fluorescent cascade assay for NanA detection in droplets, validation using a mock library, and application to functional metagenomic screening. N-acetylneurminic acid (Neu5Ac), N-acetylmannosamine (ManNAc), sialic acid aldolase (NanA), Lacatate dehydrogenase (LDH), Ketorreductase Fb (FbKRED), Fluorescence Activated Droplet Sorting (FADS). Figure created with BioRender.
Open AccessUltrahigh-throughput screening for sialic acid-active enzymes in the microbial genetic diversity
Sialic acids (Sias) and related nonulosonic acids are critical components of glycoconjugates involved in host-pathogen interactions, immune regulation, and cell signalling. Despite their biotechnological relevance, the diversity of enzymes involved in Sia biosynthesis remains largely underexplored due to limitations in culture-dependent methods and the lack of (ultra)high-throughput screening strategies. Here, we report the development of a highly sensitive droplet-based microfluidic screening platform enabling the functional discovery of sialic acid aldolases in environmental metagenomes. The method integrates a fluorescence-coupled enzymatic cascade compatible with fluorescence-activated droplet sorting (FADS), allowing the screening of >10⁶ droplets per experiment, as well as a downstream validation strategy for the selected hits. Although some limitations were identified, the system demonstrated high sensitivity and was utilised for the screening of a metagenomic library from garden soil. During this campaign, a potential new sialic acid aldolase enzyme was identified. This work establishes a generalizable framework for measuring complex, multi-step enzymatic functions at ultrahigh throughput using coupled cascades in droplets, with direct applicability to directed evolution and activity-guided functional metagenomics. Highlights: Enzymatic cascade assay reports sialic acid aldolase activity in droplets. Dual fluorescence signal enables droplet quality control and barcoding. Optimized lysis and FADS enable plasmid recovery after droplet sorting. Droplet assay enriches NanA-positive clones by over 700-fold. Soil metagenome screening retrieves aldolase-related candidates Graphical Fig. 1. Optimization of a fluorescent cascade assay for NanA detection in droplets, validation using a mock library, and application to functional metagenomic screening. N-acetylneurminic acid (Neu5Ac), N-acetylmannosamine (ManNAc), sialic acid aldolase (NanA), Lacatate dehydrogenase (LDH), Ketorreductase Fb (FbKRED), Fluorescence Activated Droplet Sorting (FADS). Figure created with BioRender.
- Open Access
- 16 September 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (38) , 20698-20706
A Microfluidics-Based Ultrahigh-Throughput Screening Unveils Diverse Ketoreductases Relevant to Pharmaceutical Synthesis
Ketoreductases (KREDs) have become increasingly valuable biocatalysts due to their ability to produce chiral alcohols with high enantioselectivity. Prior to our work, Thai et al. developed an efficient and easy assay for their discovery, but the throughput was limited. Based on their work, we developed an ultrahigh-throughput screening assay to discover KREDs. First, we optimized Thai's assay by adapting it to a droplet format and increased its throughput by combining droplet microfluidics and fluorescence-activated cell sorting (FACS). Then, we demonstrated that our new assay was reliable and sensitive by successfully screening a library of 1.5 million clones. This allowed us to discover KREDs with low identity with known enzymes or with a previously undescribed substrate scope, which could not have been predicted computationally. In conclusion, our assay was used to carry out the first metagenomic screening for KREDs in microdroplets, and it can be used to screen any large KRED library toward enzyme discovery or evolution, as well as to enable coupled ultrahigh-throughput screening assays for other enzyme activities.
- 16 September 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (38) , 20698-20706
Open AccessA Microfluidics-Based Ultrahigh-Throughput Screening Unveils Diverse Ketoreductases Relevant to Pharmaceutical Synthesis
Ketoreductases (KREDs) have become increasingly valuable biocatalysts due to their ability to produce chiral alcohols with high enantioselectivity. Prior to our work, Thai et al. developed an efficient and easy assay for their discovery, but the throughput was limited. Based on their work, we developed an ultrahigh-throughput screening assay to discover KREDs. First, we optimized Thai's assay by adapting it to a droplet format and increased its throughput by combining droplet microfluidics and fluorescence-activated cell sorting (FACS). Then, we demonstrated that our new assay was reliable and sensitive by successfully screening a library of 1.5 million clones. This allowed us to discover KREDs with low identity with known enzymes or with a previously undescribed substrate scope, which could not have been predicted computationally. In conclusion, our assay was used to carry out the first metagenomic screening for KREDs in microdroplets, and it can be used to screen any large KRED library toward enzyme discovery or evolution, as well as to enable coupled ultrahigh-throughput screening assays for other enzyme activities.
- 18 August 2025
- Published by Elsevier
- Vol. 722, 399-428
Practical high-throughput screening assays to engineer the substrate scope of transketolase variants
- 18 August 2025
- Published by Elsevier
- Vol. 722, 399-428
Practical high-throughput screening assays to engineer the substrate scope of transketolase variants
- Open Access
- 21 August 2024
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 108 (1) , 1-18
Kinetic characterization of two neuraminic acid synthases and evaluation of their application potential
Neuraminic acid synthases are an important yet underexplored group of enzymes. Thus, in this research, we performed a detailed kinetic and stability analys
- 21 August 2024
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 108 (1) , 1-18
Open AccessKinetic characterization of two neuraminic acid synthases and evaluation of their application potential
Neuraminic acid synthases are an important yet underexplored group of enzymes. Thus, in this research, we performed a detailed kinetic and stability analys
- Open Access
- 2 August 2024
- Published by Royal Society of Chemistry (RSC) in Catalysis Science & Technology
- Vol. 14 (18) , 5375-5384
Fluorescence-based pH-shift assay with wide application scope for high-throughput determination of enzymatic activity in enzyme mining and engineering
A number of enzymes important for biocatalyst development or as drug targets are associated with a pH shift during their catalytic reaction, owing to the concommitant release or uptake of protons. Here, we show that an enzyme assay developed using the fluorescent pH indicator HPTS can be adapted for reliable and continuous activity determination of representative enzymes from multiple EC classes that operate in the viable pH range 5.5–8.5, using ratiometric measurement (F485/F405). Kinetic measurements obtained with this method closely match literature values determined using other assay types. Further, the assay was employed to screen variants of transketolase from Geobacillus stearothermophilus (TKgst) aimed at engineering substrate promiscuity and remote enantioselectivity for 3-hydroxyaldehydes. The fluorescence-based assay displayed 70-fold improved sensitivity in comparison to an absorption-based assay for transketolase screening, with a limit of detection of 0.044 mM and Z-factor of 0.52. Double-site mutagenesis at the G264 and S385 positions yielded variants with 5–15-fold increased activity on the tested 3-hydroxyaldehydes compared to the TKgst (L382F) base variant. Although the directed evolution engineering strategy did not achieve significant remote enantioselectivity in this first round of mutagenesis, the simple fluorescence-based pH-shift assay was shown to be useful as a versatile primary high-throughput screen for in vitro enzyme engineering.
- 2 August 2024
- Published by Royal Society of Chemistry (RSC) in Catalysis Science & Technology
- Vol. 14 (18) , 5375-5384
Open AccessFluorescence-based pH-shift assay with wide application scope for high-throughput determination of enzymatic activity in enzyme mining and engineering
A number of enzymes important for biocatalyst development or as drug targets are associated with a pH shift during their catalytic reaction, owing to the concommitant release or uptake of protons. Here, we show that an enzyme assay developed using the fluorescent pH indicator HPTS can be adapted for reliable and continuous activity determination of representative enzymes from multiple EC classes that operate in the viable pH range 5.5–8.5, using ratiometric measurement (F485/F405). Kinetic measurements obtained with this method closely match literature values determined using other assay types. Further, the assay was employed to screen variants of transketolase from Geobacillus stearothermophilus (TKgst) aimed at engineering substrate promiscuity and remote enantioselectivity for 3-hydroxyaldehydes. The fluorescence-based assay displayed 70-fold improved sensitivity in comparison to an absorption-based assay for transketolase screening, with a limit of detection of 0.044 mM and Z-factor of 0.52. Double-site mutagenesis at the G264 and S385 positions yielded variants with 5–15-fold increased activity on the tested 3-hydroxyaldehydes compared to the TKgst (L382F) base variant. Although the directed evolution engineering strategy did not achieve significant remote enantioselectivity in this first round of mutagenesis, the simple fluorescence-based pH-shift assay was shown to be useful as a versatile primary high-throughput screen for in vitro enzyme engineering.
- Open Access
- 27 June 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (29) , 21158-21173
Cascade enzymatic synthesis of a statin side chain precursor – the role of reaction engineering in process optimization
Statins are an important class of drugs used to lower blood cholesterol levels and are often used to combat cardiovascular disease. In view of the importance of safe and reliable supply and production of statins in modern medicine and the global need for sustainable processes, various biocatalytic strategies for their synthesis have been investigated. In this work, a novel biocatalytic route to a statin side chain precursor was investigated in a one-pot cascade reaction starting from the protected alcohol N-(3-hydroxypropyl)-2-phenylacetamide, which is oxidized to the corresponding aldehyde in the first reaction step, and then reacts with two equivalents of acetaldehyde to form the final product N-(2-((2S,4S,6S)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)ethyl)-2-phenylacetamide (phenylacetamide-lactol). To study this complex reaction, an enzyme reaction engineering approach was used, i.e. the kinetics of all reactions occurring in the cascade (including side reactions) were determined. The obtained kinetic model together with the simulations gave an insight into the system and indicated the best reactor mode for the studied reaction, which was fed-batch with acetaldehyde feed to minimize its negative effect on the enzyme activity during the reaction. The mathematical model of the process was developed and used to simulate different scenarios and to find the reaction conditions (enzyme and coenzyme concentration, substrate feed concentration and flow rate) at which the highest yield of phenylacetamide-lactol (75%) can be obtained. In the end, our goal was to show that this novel cascade route is an interesting alternative for the synthesis of the statin side chain precursor and that is why we also calculated an initial estimate of the potential value addition.
- 27 June 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (29) , 21158-21173
Open AccessCascade enzymatic synthesis of a statin side chain precursor – the role of reaction engineering in process optimization
Statins are an important class of drugs used to lower blood cholesterol levels and are often used to combat cardiovascular disease. In view of the importance of safe and reliable supply and production of statins in modern medicine and the global need for sustainable processes, various biocatalytic strategies for their synthesis have been investigated. In this work, a novel biocatalytic route to a statin side chain precursor was investigated in a one-pot cascade reaction starting from the protected alcohol N-(3-hydroxypropyl)-2-phenylacetamide, which is oxidized to the corresponding aldehyde in the first reaction step, and then reacts with two equivalents of acetaldehyde to form the final product N-(2-((2S,4S,6S)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)ethyl)-2-phenylacetamide (phenylacetamide-lactol). To study this complex reaction, an enzyme reaction engineering approach was used, i.e. the kinetics of all reactions occurring in the cascade (including side reactions) were determined. The obtained kinetic model together with the simulations gave an insight into the system and indicated the best reactor mode for the studied reaction, which was fed-batch with acetaldehyde feed to minimize its negative effect on the enzyme activity during the reaction. The mathematical model of the process was developed and used to simulate different scenarios and to find the reaction conditions (enzyme and coenzyme concentration, substrate feed concentration and flow rate) at which the highest yield of phenylacetamide-lactol (75%) can be obtained. In the end, our goal was to show that this novel cascade route is an interesting alternative for the synthesis of the statin side chain precursor and that is why we also calculated an initial estimate of the potential value addition.
- Open Access
- 3 November 2023
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 365 (22) , 3861-3871
Hydroxamate Assays for High‐Throughput Screening of Transketolase Libraries Against Arylated Substrates
We recently reported that the transketolase from Geobacillus stearothermophilus (TKgst) upon acyl transfer to nitrosoarenes generates N‐aryl hydroxamic acids (HA). The latter are metal chelating compounds that in the presence of Fe(III) ions form deep‐red complexes. Here, we applied this principle to the development of a colorimetric assay in both solid‐ and liquid‐phase formats for the high‐throughput screening of TKgst and its variants. Screening a set of positive hits from a L382X/D470X library validated the specificity and sensitivity of the assays. The solid surface assay allows a clear distinction between positive and negative colonies by the naked eye in qualitative mode, and further also to measure activity in semi‐quantitative fashion in the liquid‐phase format. The assay will be important for engineering the TKgst enzyme towards improved conversion of aromatic aldehydes by their close structural analogy to nitrosoarenes.
- 3 November 2023
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 365 (22) , 3861-3871
Open AccessHydroxamate Assays for High‐Throughput Screening of Transketolase Libraries Against Arylated Substrates
We recently reported that the transketolase from Geobacillus stearothermophilus (TKgst) upon acyl transfer to nitrosoarenes generates N‐aryl hydroxamic acids (HA). The latter are metal chelating compounds that in the presence of Fe(III) ions form deep‐red complexes. Here, we applied this principle to the development of a colorimetric assay in both solid‐ and liquid‐phase formats for the high‐throughput screening of TKgst and its variants. Screening a set of positive hits from a L382X/D470X library validated the specificity and sensitivity of the assays. The solid surface assay allows a clear distinction between positive and negative colonies by the naked eye in qualitative mode, and further also to measure activity in semi‐quantitative fashion in the liquid‐phase format. The assay will be important for engineering the TKgst enzyme towards improved conversion of aromatic aldehydes by their close structural analogy to nitrosoarenes.
- Open Access
- 20 July 2022
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 364 (17) , 2972-2981
Enantioselective Synthesis of Pharmaceutically Relevant Bulky Arylbutylamines Using Engineered Transaminases
ATAs engineered for having an enlarged small binding pocket were applied for the synthesis of enantiomerically pure (R)‐benzo[1,3]dioxol‐5‐yl‐butylamine, a chiral component of human leukocyte elastase inhibitor DMP 777 (L‐694,458). Kinetic resolution of the racemic amine was performed by using the L59A variant of the (S)‐selective ATA from Chromobacterium violaceum (Cv‐ATA), providing the residual (R)‐enantiomer in excellent yield and >99% ee. At moderate enzyme loading and absence of co‐solvent, high volumetric productivity of 0.22 mol L−1 h−1 (42.5 g L−1 h−1) was achieved. Complementarily, the (S)‐enantiomer was generated via kinetic resolution using the (R)‐selective ATA‐117‐Rd11 from Arthrobacter sp. with acetone as the amino acceptor. In an alternative approach, we employed ATA‐117‐Rd11 for the asymmetric amination of the prochiral ketone precursor, which at 86% conversion gave the (R)‐benzo[1,3]dioxol‐5‐yl‐butylamine with excellent >99% ee. We further evaluated the utility of Cv‐ATA L59A for the asymmetric synthesis of pharmaceutically relevant (S)‐1‐phenylbutan‐1‐amine, a chiral component of the deubiquitinase inhibitor degrasyn (WP1130). The enzyme showed good tolerance to high concentrations of isopropylamine, producing (S)‐1‐phenylbutan‐1‐amine in enantiomerically pure form (>99% ee). magnified image
- 20 July 2022
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 364 (17) , 2972-2981
Open AccessEnantioselective Synthesis of Pharmaceutically Relevant Bulky Arylbutylamines Using Engineered Transaminases
ATAs engineered for having an enlarged small binding pocket were applied for the synthesis of enantiomerically pure (R)‐benzo[1,3]dioxol‐5‐yl‐butylamine, a chiral component of human leukocyte elastase inhibitor DMP 777 (L‐694,458). Kinetic resolution of the racemic amine was performed by using the L59A variant of the (S)‐selective ATA from Chromobacterium violaceum (Cv‐ATA), providing the residual (R)‐enantiomer in excellent yield and >99% ee. At moderate enzyme loading and absence of co‐solvent, high volumetric productivity of 0.22 mol L−1 h−1 (42.5 g L−1 h−1) was achieved. Complementarily, the (S)‐enantiomer was generated via kinetic resolution using the (R)‐selective ATA‐117‐Rd11 from Arthrobacter sp. with acetone as the amino acceptor. In an alternative approach, we employed ATA‐117‐Rd11 for the asymmetric amination of the prochiral ketone precursor, which at 86% conversion gave the (R)‐benzo[1,3]dioxol‐5‐yl‐butylamine with excellent >99% ee. We further evaluated the utility of Cv‐ATA L59A for the asymmetric synthesis of pharmaceutically relevant (S)‐1‐phenylbutan‐1‐amine, a chiral component of the deubiquitinase inhibitor degrasyn (WP1130). The enzyme showed good tolerance to high concentrations of isopropylamine, producing (S)‐1‐phenylbutan‐1‐amine in enantiomerically pure form (>99% ee). magnified image
- Open Access
- 4 November 2021
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 364 (3) , 612-621
Transketolase Catalyzed Synthesis of N‐Aryl Hydroxamic Acids
Hydroxamic acids are metal‐chelating compounds that show important biological activity including anti‐tumor effects. We have recently engineered the transketolase from Geobacillus stearothermopilus (TKgst) to convert benzaldehyde as a non‐natural acceptor substrate. Realizing the structural and electronic similarity to nitrosobenzene, we studied the TK‐catalyzed conversion of nitrosoarenes to yield N‐arylated hydroxamic acids. Here we demonstrate that wild‐type and variants of this versatile TKgst enzyme indeed induce the rapid biocatalytic conversion of variously p‐, m‐ and o‐substituted nitrosoarenes to produce a variety of corresponding N‐aryl hydroxamic acids via creation of a carbon‐nitrogen instead of a carbon‐carbon bond. Further structural modifications can be introduced by varying the donor component, such as hydroxypyruvate or pyruvate. magnified image
- 4 November 2021
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 364 (3) , 612-621
Open AccessTransketolase Catalyzed Synthesis of N‐Aryl Hydroxamic Acids
Hydroxamic acids are metal‐chelating compounds that show important biological activity including anti‐tumor effects. We have recently engineered the transketolase from Geobacillus stearothermopilus (TKgst) to convert benzaldehyde as a non‐natural acceptor substrate. Realizing the structural and electronic similarity to nitrosobenzene, we studied the TK‐catalyzed conversion of nitrosoarenes to yield N‐arylated hydroxamic acids. Here we demonstrate that wild‐type and variants of this versatile TKgst enzyme indeed induce the rapid biocatalytic conversion of variously p‐, m‐ and o‐substituted nitrosoarenes to produce a variety of corresponding N‐aryl hydroxamic acids via creation of a carbon‐nitrogen instead of a carbon‐carbon bond. Further structural modifications can be introduced by varying the donor component, such as hydroxypyruvate or pyruvate. magnified image
- Open Access
- 16 December 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 50 (3) , 1968-2009
Biocatalytic routes to anti-viral agents and their synthetic intermediates
An assessment of biocatalytic strategies for the synthesis of anti-viral agents, offering guidelines for the development of sustainable production methods for a future COVID-19 remedy.
- 16 December 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 50 (3) , 1968-2009
Open AccessBiocatalytic routes to anti-viral agents and their synthetic intermediates
An assessment of biocatalytic strategies for the synthesis of anti-viral agents, offering guidelines for the development of sustainable production methods for a future COVID-19 remedy.